DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ticlid (Ticlopidine Hydrochloride) - Published Studies

 
 



Ticlid Related Published Studies

Well-designed clinical trials related to Ticlid (Ticlopidine)

Exposure to oral S-ketamine is unaffected by itraconazole but greatly increased by ticlopidine. [2011.08]

Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers. [2010.02]

Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers. [2009.10]

The safety and efficacy of clopidogrel versus ticlopidine in Japanese stroke patients: combined results of two Phase III, multicenter, randomized clinical trials. [2009.06]

Quantitative determination of ticlopidine hydrochloride in human plasma by high-performance liquid chromatography-electronspray ionization mass spectrometry. [2009]

Comparison of sarpogrelate and ticlopidine in bare metal coronary stent implantation. [2008.05.07]

Bioequivalence of two preparations of ticlopidine evaluated using a pharmacodynamic end point. [2005.09]

A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy. [2005.08]

RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome. [2005.08]

Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting. [2005.07]

Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. [2005.04]

Comparative inhibitory effects of cilostazol and ticlopidine on subacute stent thrombosis and platelet function in acute myocardial infarction patients with percutaneous coronary intervention. [2005.01]

Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials. [2004.12]

Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study. [2004.07]

Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol. [2004.07]

Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting. [2004.05]

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation. [2004.04]

Effects of high ticlopidine doses on platelet function in acute coronary syndrome patients. [2004.01]

[Safety and efficacy of dalteparin administration for elective percutaneous interventions in patients pre-treated with aspirin and ticlopidine] [2004]

Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke. [2003.09]

Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. [2003.06.11]

Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting. [2003.06]

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. [2003.03.19]

Comparison of clopidogrel versus ticlopidine for prevention of minor myocardial injury after elective coronary stenting. [2003.02]

[Non ST elevation acute coronary syndrome. Some characteristics of coagulation and von Willebrand factor during short term use of ticlopidine or clopidogrel] [2003]

[Non ST elevation acute coronary syndrome. Parameters of fibrinolysis during short term use of ticlopidine or clopidogrel] [2003]

Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis. [2002.08]

Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial. [2002.05]

Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up. [2001.12]

Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA). [2001.11]

Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease. [2001.08]

Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. [2001.07.31]

Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: follow-up results of a randomized study. [2001.06]

Ticlopidine versus aspirin after myocardial infarction (STAMI) trial. [2001.04]

Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. [2001.03.13]

Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. [2001.02.01]

Comparison of ticlopidine and cilostazol for the prevention of restenosis after percutaneous transluminal coronary angioplasty. [2001.01]

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). [2000.08.08]

Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris. [2000.03.01]

Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin. [2000.03]

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. [2000.02.15]

Usefulness of cilostazol versus ticlopidine in coronary artery stenting. [1999.12.15]

Comparison of cilostazol versus ticlopidine therapy after stent implantation. [1999.09.01]

Ticlopidine decreases the in vivo activity of CYP2C19 as measured by omeprazole metabolism. [1999.04]

Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment. [1999.01]

[Comparative study on effect of Panax notoginseng and ticlid in treating early diabetic nephropathy] [1998.12]

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). [1998.11.17]

Pretreatment with antithrombotic agents during radiofrequency catheter ablation: a randomized comparison of aspirin versus ticlopidine. [1998.11]

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. [1998.10.20]

A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans. [1998.09.01]

Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. [1998.08.25]

Ticlopidine increases nitric oxide generation in heart-transplant recipients: a possible novel property of ticlopidine. [1998.08]

Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study Group. [1998.07]

Enhanced onset of platelet inhibition with a loading dose of ticlopidine in ASA-treated stable coronary patients. [1998.04.01]

Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. [1998.03.24]

Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCA. [1998.01]

Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. Etude de la Ticlopidine apres Pontage Femoro-Poplite and the Association Universitaire de Recherche en Chirurgie. [1997.12.11]

Antiplatelet effect of ticlopidine after coronary stenting. [1997.06]

A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study. [1997.01]

Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention Group. [1997.01]

A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients. [1997]

Asymptomatic circulating cerebral emboli and cerebral blood flow velocity under aspirin and ticlopidine in patients with cerebrovascular disease. [1996.10]

Hemostaseologic and hematologic parameters with aspirin and ticlopidine treatment in patients with cerebrovascular disease: a cross-over study. [1996.10]

Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris. [1996.08]

Effects of captopril and ticlopidine, alone or in combination, in hypertensive patients with intermittent claudication. [1996.06]

A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. [1996.01.15]

The STIMS trial: the ticlopidine experience and its clinical applications. Swedish Ticlopidine Multicenter Study. [1996]

Reduction of requirement for leg vascular surgery during long-term treatment of claudicant patients with ticlopidine: results from the Swedish Ticlopidine Multicentre Study (STIMS). [1995.07]

Long-term effects of ticlopidine on lower limb blood flow, ankle/brachial index and symptoms in peripheral arteriosclerosis. A double-blind study. The STIMS Group in Lund. Swedish Ticlopidine Multicenter Study. [1994.09]

Results of EMATAP: a double-blind placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease. [1994]

Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study. [1993.10]

Ticlopidine and antiplatelet therapy. [1993.09]

[A comparison of the gastroduodenal tolerance of ticlopidine and acetylsalicylic acid] [1993.08.13]

The effect of ticlopidine upon plasma fibrinogen levels in patients undergoing suprapubic prostatectomy. [1993.05.15]

Ticlopidine improves dialysis clearance of solutes in uremic patients by reducing blood clotting in dialyser fibers. [1993.05]

Three-month therapy with calcium-heparin in comparison with ticlopidine in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class. [1993.04]

Blood viscosity during long-term treatment with ticlopidine in patients with intermittent claudication. A double-blind study. [1993.04]

The efficacy and safety of ticlopidine and aspirin in non-whites: analysis of a patient subgroup from the Ticlopidine Aspirin Stroke Study. [1993.01]

[Ticlopidine may prevent subtotal or total occlusion of dilated lesions after percutaneous coronary angioplasty] [1993]

Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study. [1992.12]

[The effects of ticlopidine and nifedipine on platelet aggregation in patients with obliterating arteriopathy of the lower limbs] [1992.04]

A double-blind, placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease in Argentina. Design, organization and general characteristics of patients at entry. The EMATAP Group. [1992]

Ticlopidine treatment for patients with unstable angina at rest. A further analysis of the study of ticlopidine in unstable angina. Studio della Ticlopidina nell'Angina Instabile Group. [1991.12]

Decrease of fibrinogen in patients with peripheral atherosclerotic disease by ticlopidine. [1991.04]

Efficacy of ticlopidine in the prevention of thromboembolic events in patients with VVI pacemakers. [1991.02]

Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled study. [1991]

Effect of food and antacid on absorption of orally administered ticlopidine hydrochloride. [1990.08]

Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. [1990.07]

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study. [1990.05]

[Effects of ticlopidine on platelet function at rest and after exercise in patients with previous myocardial infarct. An acute crossover double-blind study] [1990.01]

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. [1989.08.24]

Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial. [1989.07]

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. [1989.06.03]

Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents. [1989.01]

Long-term effects of ticlopidine on fibrinogen and haemorheology in patients with peripheral arterial disease. [1988.12.15]

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results. [1988.10]

Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications. [1988.09]

Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study. [1987.11]

Well-designed clinical trials possibly related to Ticlid (Ticlopidine)

Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke. [2015]

Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. [2014]

SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. [2014]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017